Form 483

doTERRA Manufacturing, LLC Form 483, 2014-10-28

FDA issued a Form 483 to doTERRA Manufacturing, LLC on 2014-10-28 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

doTERRA Manufacturing, LLC · Pleasant Grove, United States · Issued October 28, 2014

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Oct 2014
21 CFR 111.113(a)(1)

QC production, process control; material review, disposition

Cited by Matthew A Johnson, Christine L Williams

28 Oct 2014
21 CFR 111.120(b)

QC operations -specifications; components, packaging, labels

Cited by Matthew A Johnson, Christine L Williams

28 Oct 2014
21 CFR 111.205(a)

Master manufacturing record - each batch

Cited by Matthew A Johnson, Christine L Williams

28 Oct 2014
21 CFR 111.255(b)

Batch record - complete

Cited by Matthew A Johnson, Christine L Williams

28 Oct 2014
21 CFR 111.410(b)

Label, packaging - discrepancies

Cited by Matthew A Johnson, Christine L Williams

Inspected site

DMdoTERRA Manufacturing, LLCPleasant Grove, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.113(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.120(b)Cited across public-safe Form 483 observations1x
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.255(b)Cited across public-safe Form 483 observations1x
21 CFR 111.410(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere